A tEMTing target? Clinical and experimental evidence for epithelial-mesenchymal transition in the progression of cutaneous squamous cell carcinoma (a scoping systematic review)
Abstract Cutaneous squamous cell carcinoma (cSCC) is a disease with globally rising incidence and poor prognosis for patients with advanced or metastatic disease. Epithelial-mesenchymal transition (EMT) is a driver of metastasis in many carcinomas, and cSCC is no exception. We aimed to provide a sys...
Main Authors: | Benjamin Genenger, Jay R. Perry, Bruce Ashford, Marie Ranson |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2022-06-01
|
Series: | Discover Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1007/s12672-022-00510-4 |
Similar Items
-
Cancer Progression Gene Expression Profiling Identifies the Urokinase Plasminogen Activator Receptor as a Biomarker of Metastasis in Cutaneous Squamous Cell Carcinoma
by: Elahe Minaei, et al.
Published: (2022-04-01) -
Sex as a Predictor of Response to Immunotherapy in Advanced Cutaneous Squamous Cell Carcinoma
by: Nicholas Yeo, et al.
Published: (2023-10-01) -
PIK Your Poison: The Effects of Combining PI3K and CDK Inhibitors against Metastatic Cutaneous Squamous Cell Carcinoma In Vitro
by: Jay R. Perry, et al.
Published: (2024-01-01) -
Elevated PLAUR is observed in the airway epithelium of asthma patients and blocking improves barrier integrity
by: Michael A. Portelli, et al.
Published: (2023-10-01) -
Inhibition of Urokinase-Type Plasminogen Activator Expression by Macelignan in Porphyromonas gingivalis Supernatant-Induced Human Oral Epithelial Cells
by: YANTI
Published: (2010-03-01)